Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-center, 12-month Trial of a Lunasin Regimen for Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT02709330 is registered in ClinicalTrials.gov with Richard Bedlack, M.D., Ph.D. as lead sponsor.

NCT NCT02709330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-center, 12-month Trial of a Lunasin Regimen for Patients With Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Richard Bedlack, M.D., Ph.D.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
September 13, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als (amyotrophic lateral sclerosis)